Dyslipidemia

What are the in" rel="nofollow">intensities of statin" rel="nofollow">ins and when is each in" rel="nofollow">indicated (and why does simvastatin" rel="nofollow">in 80mg not appear in" rel="nofollow">in the new guidance)? • Example: what in" rel="nofollow">intensity statin" rel="nofollow">in should a diabetic be on ? • Example: what in" rel="nofollow">intensity ststain" rel="nofollow">in should a patient with clin" rel="nofollow">inical ASCVD be on • Example: what if my 10 year risk was 6% or 22 % -What type of monitorin" rel="nofollow">ing is in" rel="nofollow">indicated? Consider especially LFTs and CK! -how are side effects managed (eg muscle pain" rel="nofollow">in with statin" rel="nofollow">ins)? • See 2013 ACC/AHA Guidelin" rel="nofollow">ine on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in" rel="nofollow">in Adults recommendations -what do the 2013 guidelin" rel="nofollow">ines say about add on therapies (fibrates, absorption in" rel="nofollow">inhibitors, etc) -The text address other guidelin" rel="nofollow">ines such as 2004 ATPIII guidance which does advocate add on therapies for additional LDL lowerin" rel="nofollow">ing. What "other" cholesterol medications are there (eg Niacin" rel="nofollow">in to in" rel="nofollow">increase HDL, fibrates for TGs) and how are they monitored and side effects managed (if at all)?